Pharmaceuticals

mRNA Cancer Vaccines And Therapeutics Market Forecast 2026–2035 Showcasing Industry Insights and Data Patterns

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The mRNA Cancer Vaccines And Therapeutics Market Over The 2026–2030 Period?

The mrna cancer vaccines and therapeutics market size has expanded rapidly in recent years. It is forecast to increase from $71.22 billion in 2025 to $82.67 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.1%. This historical growth can be linked to the successful deployment of mrna platforms in infectious disease vaccines, progress in cancer immunology research, a better understanding of tumor antigens, early clinical validation of mrna cancer therapies, and rising public and private funding for oncology innovation.

The mrna cancer vaccines and therapeutics market is anticipated to experience substantial growth over the coming years. It is forecast to achieve a valuation of $141.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. This projected expansion during the forecast period is driven by the increasing global incidence of cancer, the rising demand for customized and targeted cancer treatments, an enlargement of mrna manufacturing capabilities, a growing number of oncology clinical trials employing mrna platforms, and strategic partnerships between biotech and pharmaceutical enterprises. Significant trends for the forecast period encompass the increasing acceptance of personalized cancer vaccines, the extension of mrna-based therapeutics into applications beyond oncology, an intensified focus on the development of neoantigen-specific vaccines, an expanding clinical pipeline for mrna cancer immunotherapies, and greater investment in scalable mrna manufacturing platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

What Drivers Are Expected To Influence The mRNA Cancer Vaccines And Therapeutics Market During The Forecast Period?

The increasing occurrence of cancer is projected to stimulate the expansion of the mRNA cancer vaccine and therapeutic market in the future. Cancer encompasses a range of illnesses marked by the unregulated proliferation and dispersion of atypical cells, which can infiltrate and harm healthy tissues. The growing frequency of cancer is primarily linked to elements like inactive lifestyles, inadequate nutritional practices, and exposure to ecological poisons, all contributing to an elevated risk of diverse cancers. mRNA cancer vaccines and therapeutics are vital for enhancing cancer treatment, facilitating tailored, precise immune reactions that aid the body in more efficiently recognizing and eradicating cancer cells, consequently bettering treatment results. As an illustration, in January 2024, the American Cancer Society, Inc., a US-based cancer advocacy organization, projected that the United States would see over 611,000 cancer-related deaths in 2024, averaging more than 1,600 fatalities per day. Consequently, the increasing prevalence of cancer is fueling the expansion of the mRNA cancer vaccine and therapeutic market.

How Is The mRNA Cancer Vaccines And Therapeutics Market Segmented Across Key Categories?

The mrna cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:

1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas

2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer

3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Which Upcoming Trends Are Expected To Influence The mRNA Cancer Vaccines And Therapeutics Market?

Leading firms within the mRNA cancer vaccines and therapeutics market are concentrating on creating cutting-edge solutions, including personalized neoantigen vaccines, with the goal of boosting immune responses and increasing survival rates for cancer patients. These personalized neoantigen vaccines represent cancer treatments custom-built for individual patients, leveraging distinct tumor-specific mutations to prompt the immune system to identify and eliminate cancerous cells. An example of this is the collaboration formed in July 2023 between Merck & Co., Inc., a US-based biopharmaceutical firm focused on research, and Moderna Therapeutics, Inc., a US-based biotechnology enterprise. They commenced a randomized Phase 3 clinical trial, designated V940-001, which aims to assess mRNA-4157 (V940) combined with KEYTRUDA (pembrolizumab) for use as an adjuvant therapy in individuals with resected high-risk (Stage IIB-IV) melanoma. This trial proceeds after promising outcomes from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, where the combination demonstrated a significant advantage compared to KEYTRUDA by itself in lowering the risk of recurrence and distant metastasis. The objective of the Phase 3 trial is to corroborate these prior results by measuring relapse-free survival and distant metastasis-free survival as its primary and secondary endpoints, in that order.

Who Are The Dominant Players Shaping The mRNA Cancer Vaccines And Therapeutics Market Landscape?

Major companies operating in the mrna cancer vaccines and therapeutics market are BioNTech SE, Moderna Therapeutics Inc., CureVac N.V., Arcturus Therapeutics Holdings Inc., Immatics Biotechnologies GmbH, Argos Therapeutics Inc., Anima Biotech, Translate Bio, eTheRNA Immunotherapies NV, Gritstone bio Inc., Neon Therapeutics, Codiak BioSciences, Cartesian Therapeutics, Replimune Group Inc., Precision BioSciences, Acuitas Therapeutics, Ethris GmbH, Strand Therapeutics, Crown Bioscience, Roche (Hoffmann-La Roche AG)

Read the full mrna cancer vaccines and therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Which Region Is Forecast To Lead The mRNA Cancer Vaccines And Therapeutics Market In Terms Of Market Size?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna cancer vaccines and therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored mRNA Cancer Vaccines And Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Browse Through More Reports Similar to the Global mRNA Cancer Vaccines And Therapeutics Market 2026, By The Business Research Company

Mrna Cancer Vaccines And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Mrna Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795